The research suggests the nature and outcome of medulloblastoma relapse are biology and therapy dependent, providing translational opportunities for improved disease management through ongoing surveillance, prognostication, and risk-stratified selection of second-line treatments.
Reaching more than $140 million in total to date, Repare Therapeutics completed an $82.5 Series B financing with the aim of pushing two of...
UAB researchers uncover a mechanism that reprograms the hearts of ischemic cardiomyopathy patients, paving the way for precision care
TBK1, already a known genetic cause of ALS and frontotemporal dementia, is tied to age-related neurodegeneration
Chromatrap has launched a range of Chromatin Immunoprecipitation (ChIP)-validated antibodies, which are vital to modern epigenetic research
Pathway Genomics and IBM unveiled the closed-alpha release of Pathway Genomics OME™ app, powered by Watson. The app merges cognitive computing and deep learning...
With CRISPR technology use increasing, views vary widely on associated ethical issues and whether restrictions are needed on its use.
Platform combines testing of thousands of genetic markers with data on environmental factors and a specialist review of the data
Researchers in Japan identify Chrm1 and Chrm3 genes as necessary for rapid eye movement sleep
Researchers conduct comprehensive genetic and epigenetic analysis of 137 testicular germ cell tumors, which could enhance treatment choices